|
AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and … AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster AstraZeneca share price: Novel drug shows positive results for severe asthma AstraZeneca's benralizumab succeeds in severe asthma |
View full post on asthma – Google News